DNER and neoplasm: ABBV-075 is a novel BET inhibitor exhibited significant inhibitory effect on tumor growth in Kasumi-1 cells xenograft mice model (McDaniel et al., 2017) and prostate cancer which provides a new option for therapeutic treatment of CRPC patients (Faivre et al., 2017).